2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of garadacimab in the NHS in England.

For the time being, garadacimab should not be used for the prevention of recurrent attacks of hereditary angioedema in patients 12 years of age and older.

Read NICE draft guidance consultation